Revolutionizing the Treatment of Autoimmune Diseases
Addressing significant unmet needs in the field of autoimmunity through the development of novel patented therapies for treatment of disease.
AnTolRx’s vision is to build a platform that selectively targets pathogenic immune cells providing a unique tolerogenic signal to induce an anti-inflammatory phenotype and better treat diseases.
Kenison, J.E. et al. PNAS doi: 10.1073/pnas.2016451117. PMID: 33239445 (2020).